Skip to content

Clinical trials

Completed Myeloproliferative Disorders trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Phase: Not applicable Status: Completed Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20012
20023
20033
20042
20051
20062
20071
20081
20091
20101
20121
20133
20142
20171
20181
20192
20201
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center6
City of Hope Medical Center2
Roswell Park Cancer Institute2
Stanford University2
University of California, San Francisco2
University of Washington2
Wake Forest University Health Sciences2
Advice Pharma Group srl1
Arizona State University1
Barbara Ann Karmanos Cancer Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders40
Primary Myelofibrosis27
Hodgkin Disease26
Leukemia, Myeloid, Acute26
Precursor Cell Lymphoblastic Leukemia-Lymphoma26
Lymphoma, Non-Hodgkin25
Leukemia, Lymphocytic, Chronic, B-Cell24
Multiple Myeloma24
Lymphoma, Mantle-Cell22
Burkitt Lymphoma21

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.